BIOPHYTIS S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.85 EUR | 0.00% |
|
+1.19% | -58.33% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Biophytis S.A. is a biotechnology company in the clinical stage specialized in the development of drug candidates to slow degenerative processes and improve functional capacity in patients with age-related diseases, including respiratory failure in patients suffering from COVID-19.
The company is located in Paris, France and Cambridge, Massachusetts.
| 1st Jan change | Capi. | |
|---|---|---|
| -58.33% | 2.52M | |
| +2.79% | 108B | |
| +10.00% | 105B | |
| +1.66% | 23.46B | |
| -11.85% | 21.72B | |
| -7.05% | 18.64B | |
| -38.55% | 17.45B | |
| -7.24% | 17.19B | |
| +6.04% | 13.99B | |
| +35.15% | 12.53B |
- Stock Market
- Equities
- ALBPS Stock
- ALBPS Stock
- News Biophytis S.A.
- Top Premarket Decliners